ERBB2 and breast cancer: Interestingly, analysis of COX-2 expression levels across different molecular subtypes, using different classification methods in both databases, revealed that high COX-2 expression correlated with the most aggressive basal-like breast cancer subtype, compared to HER2 and luminal tumors (Fig. 1a–c and Fig. S1a–c).